Clinical Trial Update: The Prophylactic Effect of Stilamin on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis [NA]

View source ↗

Summary

This entry reports a clinical trial evaluating the prophylactic effect of Stilamin on post-ERCP pancreatitis, with current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

Drugs mentioned

• Stilamin

Snippet

Sponsor: Changhai Hospital | Conditions: Post-ERCP Acute Pancreatitis | NA | Status: UNKNOWN